ADAG
Adagene Inc.
$4.47
-0.31 (-6.49%)
At close · Jul 2
Market Cap
$295.34M
Shares
59,231,993
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$30,000,000
as of 2022-06-29
· total across 2 concurrent programs
Concurrent Repurchase Programs
| Authorized | As of | Remaining | Remaining as of | Source |
|---|---|---|---|---|
| $10,000,000 | 2022-06-29 | — | — | 20-F, filed 2025-03-24 |
| $20,000,000 | 2021-07-07 | — | — | 20-F, filed 2025-03-24 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $3,976,681 | 20-F, filed 2025-03-24 |
| 2021-12-31 | $2,361,576 | 20-F, filed 2024-03-29 |